09.10.2023

Cordis gibt die Ernennung von Scott Drake zum Executive Chairman des Aufsichtsrats bekannt

Read more

19.10.2022

Cordis gibt Übernahme von MedAlliance bekannt

Cordis gab heute die Übernahme von MedAlliance bekannt, einem in der Schweiz ansässigen Unternehmen, das bei der Entwicklung neuer medikamentenfreisetzender Ballons führend ist.

Read more

14.07.2022

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion...

Read more

14.07.2022

Cordis Names Muscari President Of The Americas

Matthew Muscari takes the helm of global marketing and American sales as Cordis pursues path of transformation and growth

Read more

14.07.2022

Cordis names Christopher Scully to CFO Post

Cordis, a global interventional cardiovascular technology company, today announced that Christopher Scully has joined the organization as Chief Finan...

Read more

14.07.2022

Cordis Makes Strategic Investment in E2

Cordis Makes Strategic Investment in E2, a developer of Next-Generation Thrombectomy Devices Move signals new chapter of innovation for Cordis

Read more

14.07.2022

Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Cordis Pays Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Read more

14.07.2022

Cordis Announces Successful First-in-Human Use of the Radianz Radial Peripheral System™

Read more

14.07.2022

Cordis Names Bryan Loo President Of The Asia-Pacific Region

Bryan Loo will head a leadership team responsible for the fast-growing APAC region for Cordis.

Read more